相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk of COVID-19 for patients with cancer
Hanping Wang et al.
LANCET ONCOLOGY (2020)
COVID-19 and its implications for thrombosis and anticoagulation
Jean M. Connors et al.
BLOOD (2020)
Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy
Gordon Cook et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
Lennard Y. W. Lee et al.
LANCET (2020)
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Nicole M. Kuderer et al.
LANCET (2020)
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study
Kunyu Yang et al.
LANCET ONCOLOGY (2020)
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations
Jason Phua et al.
LANCET RESPIRATORY MEDICINE (2020)
Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts
Amer M. Zeidan et al.
LANCET HAEMATOLOGY (2020)
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review
W. Joost Wiersinga et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
Marina Chiara Garassino et al.
LANCET ONCOLOGY (2020)
Respiratory Virus Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient
Lauren Fontana et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2019)
Low clinical trial accrual of patients with myelodysplastic syndromes: Causes and potential solutions
David P. Steensma et al.
CANCER (2018)
Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions
R. W. F. van Leeuwen et al.
ANNALS OF ONCOLOGY (2015)
Prognosis-related factors in intensive care unit (ICU) patients with hematological malignancies: A retrospective cohort analysis in a Chinese population
Jing Liu et al.
HEMATOLOGY (2015)
Azithromycin and the Risk of Cardiovascular Death
Charles A. Knirsch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Azithromycin and the Risk of Cardiovascular Death
Wayne A. Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Potential for drug interactions in hospitalized cancer patients
RP Riechelmann et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Patients with haematological malignancies requiring invasive mechanical ventilation: differences between survivors and non-survivors in intensive care unit
R Owczuk et al.
SUPPORTIVE CARE IN CANCER (2005)
Performance of six severity-of-illness scores in cancer patients requiring admission to the intensive care unit: a prospective observational study
M Soares et al.
CRITICAL CARE (2004)
Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication
DD Benoit et al.
CRITICAL CARE MEDICINE (2003)
分享论文
